Precision Bayesian phase I-II dose-finding based on utilities tailored to prognostic subgroups (Q6628021)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: Precision Bayesian phase I-II dose-finding based on utilities tailored to prognostic subgroups |
scientific article; zbMATH DE number 7934576
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Precision Bayesian phase I-II dose-finding based on utilities tailored to prognostic subgroups |
scientific article; zbMATH DE number 7934576 |
Statements
Precision Bayesian phase I-II dose-finding based on utilities tailored to prognostic subgroups (English)
0 references
29 October 2024
0 references
adaptive randomization
0 references
Bayesian phase I-II clinical trial design
0 references
clustering
0 references
dose finding
0 references
patient prognostic subgroups
0 references
0 references
0 references
0 references
